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In vivo online magnetic resonance 
quantification of absolute 
metabolite concentrations in 
microdialysate
Stefan Glöggler1,*, Silvia Rizzitelli1,*, Noël Pinaud1, Gérard Raffard2, Vanessa Zhendre1, 
Véronique Bouchaud2, Stéphane Sanchez2, Guillaume Radecki3, Luisa Ciobanu3, Alan Wong4 
& Yannick Crémillieux1
In order to study metabolic processes in animal models of diseases and in patients, microdialysis probes 
have evolved as powerful tools that are minimally invasive. However, analyses of microdialysate, 
performed remotely, do not provide real-time monitoring of microdialysate composition. 
Microdialysate solutions can theoretically be analyzed online inside a preclicinal or clinical MRI scanner 
using MRS techniques. Due to low NMR sensitivity, acquisitions of real-time NMR spectra on very 
small solution volumes (μL) with low metabolite concentrations (mM range) represent a major issue. 
To address this challenge we introduce the approach of combining a microdialysis probe with a custom-
built magnetic resonance microprobe that allows for online metabolic analysis (1H and 13C) with high 
sensitivity under continuous flow conditions. This system is mounted inside an MRI scanner and allows 
performing simultaneously MRI experiments and rapid MRS metabolic analysis of the microdialysate. 
The feasibility of this approach is demonstrated by analyzing extracellular brain cancer cells (glioma) 
in vitro and brain metabolites in an animal model in vivo. We expect that our approach is readily 
translatable into clinical settings and can be used for a better and precise understanding of diseases 
linked to metabolic dysfunction.
Microdialysis is a valuable tool for in vivo investigations and can be placed in many tissues and organs including brain 
for neurological investigations of Alzheimer1,2, brain tumors3, traumatic brain injuries4, neuronal functionality5  
and pharmacokinetics of drugs6. In combination with magnetic resonance imaging (MRI), dialysate composition 
can be directly correlated with anatomical structures or pathological changes seen on MRI7,8. However, metabolic 
investigations of the dialysate are currently performed remotely and off-line from the MRI scanner9–12 due to the 
limited online sampling possibilities13,14. Integrating analytical devices within MRI scanners poses challenges 
(related to limited space and to magnetic interference), limiting the applications of correlation experiments. Here, 
we introduce a novel approach of online sampling of tissue dialysate under continuous flow utilizing a high 
resolution nuclear magnetic resonance (NMR) microprobe, closely coupled to an in vivo microdialysis inside 
an MRI scanner. We present two microprobes that allow for the online metabolic investigation at physiological 
concentrations (1H: 1.8 mM lactate in 60 s; 13C: 10.0 mM 3-13C lactate in 100 s). The applicability of the approach 
is demonstrated by investigating extracellular metabolites, from in vitro brain cancer cells and from in vivo micro-
dialysate of rat brain.
Results
Micro-structured NMR/MRS probes have been fabricated in a variety of different geometries15–28 and have partly 
been applied to continuous flow investigations29,30 with solenoidal coils being the most sensitive to date15,16. 
Utilizing this fact with the goal of online detection of metabolites at physiological concentrations for in vivo 
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studies, we have constructed two different microprobes with solenoidal geometry: a 1H-optimized probe tuned at 
300 MHz and a 13C-optimized probe with unprecedented sensitivity tuned at 50 MHz.
The proton and carbon-13 microcoils are respectively interfaced and positioned inside MRI scanners oper-
ating at B0 = 7.0 T and B0 = 4.7 T (Fig. 1A,B), respectively. For both probes, the detected sample volume is 1 μ L 
(2.4 mm in length and 750 μ m in diameter) with an optimal filling factor of 92.5% (the ratio of the sample volume 
to the coil detection volume). The limits of detection (LOD) for the probes, corresponding to a signal-to-noise 
ratio (SNR) of 3, are 1.8 nmol in 60 s for the methyl protons (which corresponds to 5.4 nmol for one proton) of lac-
tate and 10 nmol in 100 s for the carbon atoms in an enriched 3-13C lactate sample. Characteristics of the coils are 
summarized in Table 1 whereby the detection sensitivity has been normalized according to an established proce-
dure (see ref. [25], equation 5 and Table 1) to a field strength of B0 = 14.1 T. The sensitivities amount to 12.7 nmo-
l·s½ for the proton-optimized probe and 14.6 nmol·s½ for the carbon-optimized coil. The spectral resolution is 
optimized by placing the microcoil into a container filled with fluorinated solvent for increasing the magnetic 
field homogeneity at the site of the sample. The linewidths for the 1H- (B0 = 7 T) and 13C-optimized (B0 = 4.7 T) 
probes were determined using NMR lines from natural abundance and 13C-enriched lactate, respectively leading 
to proton linewidth of 15.0 Hz (0.05 ppm) and carbon linewidth of 3.5 Hz (0.07 ppm) inside the MRI scanners. 
The broadened line width can be explained by the increased susceptibility mismatch due to the proximity of the 
sample to the windings of the copper coil as has been previously investigated by Webb and coworkers31. Since 
we optimized the filling factor to over 90% we achieve a near optimal SNR but compromise the line-resolution. 
For 13C NMR experiments, a double resonant circuit, based on a single 13C-1H micro-size solenoid is used in 
transmit-receive mode (Fig. 1A). The circuit is optimized for 13C detection while the 1H channel can be used for 
the shimming procedure (homogenizing the magnetic field in the sample region). In addition, the 1H channel can 
Figure 1. Experimental setups. (A) Left: Circuit of the 1H/13C double resonant 13C-optimized probe for 
carbon detection at 50 MHz, right: photo illustration of the microprobe (red circles indicate the position of the 
microcoil). (B) Left: Circuit of the 1H- optimized probe for proton detection at 300 MHz with a separate 13C 
decoupling channel (75 MHz), right: photo illustration of the microprobe. (C) In vitro experiment utilizing a 
microprobe/microdialysis setup to collect and analyze extracellular glioma metabolites under a continuous flow. 
(D) In vivo setup to collect brain metabolites from a rat including the possibility of acquiring images of the brain 
with a surface proton coil (arrows indicate the flow of the buffer solution/dialysate).
Probe Frequency/MHz
Sample 
Volume/μL
Sensitivitya at 
14.1 T/nmol.s½ Linewidth/Hz
Unloaded 
Q-factor
B1/P0.5b/
mT.W−1/2
1H-optimized 300 1.0 12.7 15.0 (0.07 ppm) 50 0.6
13C-optimized 50 1.0 14.6 3.5 (0.05 ppm) 100 3.7
Table 1.  Probe characteristics. a) Normalization to 14.1 T (According to ref. [25] equation 5 and Table 1): 
nLOD = 3ns Δ t1/2 SNR-1 (Δ B0)7/4 (ns: number of spins, Δ t: effective acquisition time, SNR: measured signal-
to-noise ratio, Δ B0: difference between utilized magnetic field and 14.1 T). b) Probe efficiency: Based on the 
reciprocity principle2,25, the probe efficiency B1/P0.5 (where B1 is the RF magnetic field for a 360° pulse at a given 
transmitter power P) is directly proportional to the detection sensitivity of a probe.
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also be utilized for proton decoupling in 13C experiments to further enhance the sensitivity, this being particularly 
useful for a 13C-enriched dialysate solution. Unlike the 13C microprobe, the 1H probe consists of two independent 
resonance circuits (Fig. 1B): a micro-solenoid is used for 1H excitation, detection and B0 shimming; the second 
resonant circuit, composed of a 1.5-cm diameter loop, is used as a 13C decoupling channel.
The experimental setup for online in vitro and in vivo MR analysis of microdialysate is depicted in Fig. 1C,D. 
Inside the MRI scanner, a microdialysis probe is inserted in an Eppendorf tube containing cells or positioned 
inside the target’s brain region. The outlet-tube from the microdialysis is immediately passed through the micro-
probe for a real-time online metabolic profiling of the dialysate. Outside the scanner, the inlet-tube is connected 
to a syringe pump that continuously flows a buffer solution through the sample i.e., cells or brain.
In the in vitro study, we attempt to monitor the metabolism activities of cancer cells (glioma) supplied with 
3-13C pyruvate. As shown in Fig. 1C, the microdialysis is placed inside a buffer solution containing U87-MG 
glioma cells. The MRS (magnetic resonance spectroscopy) acquisition begins as the 3-13C pyruvate is added to 
the suspension of cells. The MRS results from the subsequent sampling with the 13C and 1H microprobes are 
depicted in Fig. 2. With the 13C-optimized microprobe (Fig. 2A), signals for 13C labeled alanine, glutamine and 
lactate are detected in less than 17 minutes (B0 = 4.7 T) whereby most of the pyruvate has already been metabo-
lized as confirmed by high-field spectroscopy experiments (see Methods section). The LOD for a measurement of 
13C-enriched metabolites on a 17-minute timescale is 3.2 mM (i.e. 3.2 nmol in 1 μ L), with a measured linewidth 
of 5.5 Hz. The same experiment was performed at B0 = 7 T with the 1H probe (Fig. 2B) by averaging over less 
than 4 minutes, and resulted in a LOD of 0.9 mM (900 pmol in 1 μ L) for three protons of the methyl group of the 
13C-enriched metabolites lactate, alanine and pyruvate (linewidth of 20.0 Hz) and an LOD of 1.4 mM for the two 
glutamine protons. Based on these LODs, single proton species are expected to be detectable if the concentration 
exceeds 2.7 mM (2.7 nmol in 1 μ L). We note that alanine and lactate signals could be better distinguishable from 
each other with an improved linewidth; the existence of both metabolites was however confirmed by high field 
NMR spectroscopy at B0 = 11.7 T (see Methods information).
Differentiation between extracellular metabolites originating from the 13C enriched pyruvate substrate and 
other endogenous substrates can be performed (1) by observing J-splitting in the presence of 1JH,C coupling, and 
(2) by performing a subsequent 13C decoupling experiment after which only one singlet becomes visible for the 
13C-enriched metabolites. For example, the spectrum from a 1H single-pulse experiment, Fig. 2B, displays the 
J-splitting for 13C-enriched pyruvate, glutamine, lactate and alanine. For residual pyruvate a J-splitting of 1JH,C ≈ 
123 Hz was observed and for glutamine 1JH,C ≈ 130.6 Hz. The splitting of the “combined” lactate and alanine spe-
cies corresponds to 129.8 Hz. Conversely, only isotropic chemical shift signals are observed in the 13C-decoupled 
experiment in Fig. 2C. Moreover, the direct 13C detection from 13C experiment also exhibits three distinct metab-
olite signals. These 1H and 13C spectroscopic results clearly confirm the presence the 13C-enriched metabolites in 
the dialysate; and thus, they indicate that the infused 13C-pyruvate has been metabolized by the cells.
In the in vivo study on a rat model, the microdialysis was inserted into the cortex of the rats’ brain via a guide 
cannula and connected to the inlet of the 1H probe. Under continuous flow with buffer solution that included 
3 mM of DOTAREM® (Gd-DOTA and meglumine), the dialysate brain metabolites were analyzed. The gado-
linium contrast agent serves three purposes: (1) monitoring the activity of the microdialysis inside the rat brain 
using MRI (Fig. 3A); (2) shortening the 13C longitudinal relaxation time for faster NMR acquisition; and (3) 
serving as an internal reference (the line of the meglumine methyl 1H appears at 2.8 ppm) for the NMR chem-
ical shift as well as for the concentration. Fig. 3B depicts the time course for the in vivo experiments. In the 
beginning, when the perfusate flow is started, only protons of water and protons from meglumine are detected 
by the microcoil. The dialysate reaches the microcoil after 35 minutes and the extracellular brain metabolites 
Figure 2. In vitro experiments on glioma cells. (A) 13C spectrum of extracellular glioma metabolites in the 
dialysate after the addition of enriched 3-13C-pyruvate; acquired under continuous flow in 1000 s at B0 = 4.7 T 
(50 MHz). (B) 1H spectrum of extracellular glioma metabolites acquired after the addition of 3-13C-pyruvate at 
B0 = 7 T (300 MHz). The 1H-13C J-splitting shown in the spectrum indicates that the MRS-detected metabolites 
are originated from the supplied 3-13C-labeled pyruvate. (C) 13C decoupled spectrum shows the isotropic 
chemical shift signals of the metabolites from the microdialysate (differences in chemical shift compared to  
(B) are due to the Bloch-Siegert shift upon a strong decoupling field).
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become detectable at 1.2 ppm in the 1H NMR spectrum (0.7 mM concentration). The 35 minutes delay is due to 
the approximately 18 μ L volume of tubing placed between the rat and the RF coil. This delay can be significantly 
reduced using shorter tubing with a smaller inner diameter. We expect that with an optimized tubing the volume 
can be reduced down to 1 μ L which will allow for acquiring the first spectrum within a few minutes, making it 
more practical for in vivo use with patients. After 43 minutes the equilibrium concentration of lactate from the rat 
brain can be detected, which stays constant over the course of the experiment (139 minutes). The comparison with 
the meglumine standard reveals that a concentration of 1.1 mM extracellular lactate from the brain is detected 
at equilibrium. The existence of the lactate metabolite was further proven by high-field NMR spectroscopy 
(see Methods section).
With respect to translatability to clinical patients, we see great potential in combination with ultrahighfield 
MRI systems for which wholebody scanners up to 7T exist32. Although we present in our article the study of the 
brain in animal models, we would like to note that the use of microdialysis in connection with clinical patients is 
possible in many different organs. For examples, microdialysis probes have been applied to breast cancer research, 
and to liver, adipose tissue or skeletal muscle in vivo studies of patients33–35. Furthermore, clinical studies to probe 
pharmacokinetics and visualization with gadolinium contrast agents have been performed previously. However 
with the approach present here, it is now possible to carry out the measurement inside the MRI scanner without 
the necessity of performing the analysis at a remote place36. An advantage with clinical patients is that larger 
microdialysis membranes are used for sampling37. Thus, higher amounts of sample can be analyzed in slightly 
larger NMR microprobes which will further increase the SNR. Lastly, we expect that the microprobes are not only 
combinable with surface coil but could also be used together with volume coils. In this case, care has to be taken 
that the microprobe is still mounted inside a homogeneous region of the MRI system but far enough away from 
the imaging region to prevent artifacts.
Figure 3. In vivo experiments. (A) T1-weighted MR images in axial (top) and sagittal (bottom) planes of 
microdialysis probe positioning before (left images) and after (right images) flowing the perfusate. The bright 
area demonstrates the diffusion of Gd-DOTA through the microdialysis membrane into the rat brain. (B) Time 
course of the spectroscopy experiments with the 1H-optimized microprobe at B0 = 7 T. The bottom line is the 
starting spectrum at t = 0 in which only the meglumine standard (left peak at 2.7 ppm) is visible. After t = 35 min 
lactate becomes observable (right peak at 1.3 ppm), the equilibrium is reached after 43 minutes (i.e. no increase in 
lactate concentration is visible over the course of a 139-minute experiment) and 1.1 mM lactate is detected in the 
dialysate under continuous flow and 3 minutes and 50 seconds of NMR acquisition.
Figure 4. 1H spectrum of an in vitro control experiment. Upon the absence of 3-13C pyruvate no 13C enriched 
source is detected. Lactate in natural abundance from an internal source is detected which is identified in 
the high field spectrum as well during the 13C experiments (see Fig. 5). However no other metabolites are 
identifiable in this control experiment.
www.nature.com/scientificreports/
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We expect that the online MR metabolic analysis of microdialysate presented in this study opens new perspec-
tives for metabolite profiling. The particular strength of the approach lies in the possibility to perform metabolic 
analysis in rapid succession of imaging experiments on a timescale of 3 to 20 minutes in order to investigate 
the metabolic evolution under chemiotherapeutic treatment or neural activity. As proof-of-principle in vivo 
experiments, we have successfully detected highly concentrated lactate (1.1 mM in the dialysate) with the micro-
coil. Lower concentrated metabolites are expected to become detectable with lower flow rates allowing for an 
improved exchange of metabolites into the membrane and by improving the microprobe. Further increases in 
resolution and sensitivity can be expected by utilizing higher order shims, by increasing the microcoil volume or 
by building microcoils for MRI scanners operating at higher magnetic fields.
The application of this combined microprobe and microdialysis systems is not only limited to the brain 
study, but it can also be implemented in other organs or living tissues. As microdialysis probes are being used 
in vivo in humans4 and microcoil probes are being utilized for human exploration18, we further expect that the 
MR approach presented here could be applied in clinical settings.
Methods
Microcoil design. The double-parallel microcoils (length = 2.4 mm) were handwound with 30 μ m (13C 
probe, 80 windings) or 62.5 μ m (1H probe, 38 windings) copper wire around a polyimide tubing (inner diam-
eter = 750 μ m and outer diameter = 780 μ m) that was supported during the winding process by a glass capillary 
and was removed afterwards. The lower and upper end of the coil are supported by a larger polyimide tubing 
(inner diameter = 800 μ m and outer diameter = 858 μ m), eliminating the necessity of using glue, which may com-
promise the probe’s quality, for coil fixation. The coils were placed inside a 2 ml Eppendorf tube which was filled 
with FC-70 fluid.
Figure 5. 13C spectrum of the in vitro dialysate (dialysis experiment performed at B0 = 4.7T) detected at 
B0 = 11.7 T. 
Figure 6. 1H spectrum of the in vitro dialysate (dialysis experiment performed at B0 = 7T) detected at 
B0 = 11.7 T. 
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Chemicals. Sodium L-lactate-3-13C solution, Sodium pyruvate-3-13C, D2O and all the inorganic salts were 
purchased from Sigma-Aldrich (St Louis, MO, USA), and used without further purification. Dotarem® was 
provided by Guerbet Group (Villepinte, France). The culture medium DMEM, the biological buffers, foetal calf 
serum (FCS), penicillin-streptomycin mixture, and trypsin were purchased from Gibco Corp - Thermo Fisher 
Scientific (Waltham, MA, USA).
Cell culture. Human glioblastoma U87-MG cell line, purchased by ATCC (LGC standards, Middlesex, UK), 
were cultured as monolayer at 37 °C in a 5% CO2-containing humidified atmosphere. The culture medium 
was composed of Dulbecco’s modified eagle medium (DMEM low glucose content and contains L-glutamine, 
reference 31885) supplemented with 10% (v/v) heat-inactivated FCS, 100 IU/mL penicillin, and 100 IU/mL 
streptomycin.
Experimental cell setup. Cells were separated from DMEM by centrifugation and washing with PBS buffer 
prior to the experiment. 7 × 106 cells were suspended in 300 μ L of PBS buffer within an Eppendorf tube. With 
the aim of keeping the cells in suspension, a plastic tubing connected to an infusion pump for air injection was 
inserted into the cells solution leading to continuous stirring. The cell suspension was heated to 37 °C in all exper-
iments with external circulating warm water. The temperature was checked with a thermocouple. No temperature 
induced shift in the resonances was observed during the experiments. A microdialysis probe was placed into the 
cells suspension and infused with a buffer solution (PBS in D2O containing 3 mM Dotarem® ) under a flux of 
500 nL/min with the use of an infusion pump (Legato 110, Phymep, Paris, France). The outlet tube of the micro-
dialysis probe was inserted into the microcoil tube to analyse the dialysate by MR spectroscopy. 3–13C sodium 
pyruvate solution was added to yield an overall concentration of 150 mM. The experiment was continuously 
performed for 2 hours.
Additionally, a control experiment without 13C-pyruvate was performed (Fig. 4).
Figure 7. HSQC (Heteronuclear Single Quantum Correlation) spectrum of the in vitro dialysate 
(dialysis experiment performed at B0 = 7T) detected at B0 = 11.7 T to confirm the existence of 13C labeled 
metabolites. 
Figure 8. 1H spectrum of the in vivo dialysate detected at B0 = 11.7 T. 
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Animal model. Adult female Wistar rats of 250 g weights were purchased from Charles River Laboratories 
and kept in standard housing (12 h light-dark cycles) with a standard rodent chow and water available ad libitum. 
Before the beginning of the experiment, the animals were acclimatized in a temperature-controlled environ-
ment for one week. Experiments were performed according to the national regulations and were approved by the 
research ethics committee of the University of Bordeaux. The animals were anesthetized with 2.5% isofluorane in 
a mixture of N2/O2 (70:30) via a facial mask.
Microdialysis Implantation. Microdialysis CMA7 metal free catheters (CMA microdialysis AB, Solna, 
Sweden) with molecular weight cutoffs of 6 kDa were sterilized and inserted into the brain of healthy rats. Sterile 
surgical procedures were used during the implantation of the microdialysis probes. The rats were deeply anes-
thetized and positioned in a stereotaxic instrument. The head was shaved and the skull was incised coronally 
between the ears, along the interaural line. Three small holes were created in the skull using a micro drill. In two 
holes, plastic screws were inserted while in the third hole a cannula guide was placed. The screws and the guide 
were fixed on the skull with dental glue and then the muscles and the skin were sutured. Following the surgery, the 
animals were housed individually and received doses of buprenorphine 0.05 mg/kg every 12 hours for 48 hours. 
Typically, the MR experiments took place 24 hours after the surgery.
In vivo setup. The rat was positioned in prone position and the microdialysis was placed into the guide 
reaching the targeted region of the brain. A 8 mm surface dual channel-coil (Doty Scientific, Columbia, South 
Carolina) was placed over the microdialysis probe on the rat head. MRI T1 weighted scans (Flash sequence, 
Repetition Time 75.51 ms, Echo Time 2.6 ms, 6 averages, acquisitions time 1.25 min, matrix size 256 × 256, slice 
thickness 1 mm, Field of View 35 × 35 mm) were performed to assess the well-positioning of the microdialysis 
probe and the effective release of Dotarem® in the cortical region. The outlet tube of the microdialysis probe was 
inserted into the microcoil tube to analyse the dialysate by MR Spectroscopy. The microdialysis probe was infused 
with a buffer solution (PBS in D2O containing 3 mM Dotarem® 3 mM) under a flux of 500 nL/min.
MR Experiments. 1H experiments, in vitro and in vivo, were performed on a Bruker Biospec 12-cm bore 7.0 
T using Paravision 6.0 software. A series of spectra (Single-pulse sequence, Repetition Time 1145 ms, 200 aver-
ages, acquisition duration 511.2 ms, spectral resolution 1.00 Hz/points, excitation pulse length 7.5 μ s, flip angle 
35°, excitation pulse power 250 mW, acquisition time 3.82 minutes, water suppression pulse, decoupling pulse) 
was acquired to check the metabolic evolution of dialysate.
13C experiments on U-87 cells were performed on a Bruker Biospec 12-cm bore 4.7 T using ParaVision 6.0 
software. A series of spectra (Single Pulse sequence, Repetition Time 501.3 ms, 2000 averages, acquisition dura-
tion 500.0 ms, spectral resolution 1.00 Hz/points, excitation pulse length 10 μ s,flip angle 50°, excitation pulse 
power 125 mW, acquisition time 16.71 minutes, decoupling pulse) was acquired to check the metabolic evolution 
of the dialysate.
High-field analysis of dialysates. High spectral resolution NMR experiments were performed on a 
Bruker DPX 500 MHz equipped with a BBI probe to confirm metabolites detection in MRI scanner. 1H spectra 
were obtained at 500.13 MHz through single pulse sequences (zg sequence, 128 scans, TD 16k, D1 1s) and single 
pulse with water suppression sequences (zgpr, 128 scans, TD 16k, D1 3s). 13C spectra were obtained at 125 MHz 
through single pulse excitation with power gate decoupling sequences (zgpg sequence, 128 scans, TD 16k, D1 1s). 
2D HSQC 1H/13C acquisition was performed to determine the metabolites originating from enriched 13C pyru-
vate. We would like to note, that the observed metabolites in the high- field spectra depicted in Figs 5–8 may have 
a different concentration than in the microcoil experiments since the spectroscopy experiment was run with the 
complete dialysate instead of measuring small portions of it.
Ethical approval. Experiments were carried out following the INSERM (Institut National de la Santé et de 
la Recherche Médicale) guidelines regarding the fair treatment of animals with approval of the Comité d’Ethique 
en Expérimentation Animale de Bordeaux.
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